Two individuals had pathogenic variants in CHEK2 (c.1427C > T p.Thr476Met and c.1100delC p.Thr367fs), which is known to be associated with a predisposition to mainly breast cancers, and other cancers including CRC. This evidence concerns the gene CHEK2 and breast carcinoma.